Trial Profile
The effect of Irbesartan for cardiac function in patients with atrial fibrillation
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2012
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Atrial fibrillation; Hypertension
- Focus Therapeutic Use
- 17 Aug 2012 New trial record